Literature DB >> 12453470

Interleukin-15 interactions with interleukin-15 receptor complexes: characterization and species specificity.

June Eisenman1, Minoo Ahdieh, Courtney Beers, Kenneth Brasel, Mary K Kennedy, Tiep Le, Timothy P Bonnert, Raymond J Paxton, Linda S Park.   

Abstract

Interleukin (IL-) 2 and IL-15 share the IL-2 receptor betagamma c subunits (IL-2Rbetagamma c) but have specific, unique alpha receptor subunits. We studied species specificity of human (hu), simian (si), and mouse (mu) IL-15 and found that hu and si IL-15 behaved similarly in all systems investigated. Hu and mu IL-15 bound hu or mu IL-15Ralpha with equal high affinity in the presence or absence of IL-2Rbetagamma c and exhibited similar proliferative activities on cells containing all three subunits. However, quantitative differences were noted in the specific activity of hu and mu IL-15 in both in vitro and in vivo systems utilizing IL-2Rbetagamma c in the absence of IL-15Ralpha. These data show that hu IL-15 may be used in mouse model systems, however care must be taken when comparing the efficacy and toxicity of cytokines across species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453470     DOI: 10.1006/cyto.2002.1989

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

Review 1.  Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells.

Authors:  Zheng Hu; Yong-Guang Yang
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

2.  Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.

Authors:  Mark P Rubinstein; Marek Kovar; Jared F Purton; Jae-Ho Cho; Onur Boyman; Charles D Surh; Jonathan Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

3.  Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models.

Authors:  Peter R Rhode; Jack O Egan; Wenxin Xu; Hao Hong; Gabriela M Webb; Xiaoyue Chen; Bai Liu; Xiaoyun Zhu; Jinghai Wen; Lijing You; Lin Kong; Ana C Edwards; Kaiping Han; Sixiang Shi; Sarah Alter; Jonah B Sacha; Emily K Jeng; Weibo Cai; Hing C Wong
Journal:  Cancer Immunol Res       Date:  2015-10-28       Impact factor: 11.151

4.  Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains.

Authors:  Leah Alabanza; Melissa Pegues; Claudia Geldres; Victoria Shi; Jed J W Wiltzius; Stuart A Sievers; Shicheng Yang; James N Kochenderfer
Journal:  Mol Ther       Date:  2017-07-27       Impact factor: 11.454

Review 5.  Tracking migration during human T cell development.

Authors:  Joanna Halkias; Heather J Melichar; Kayleigh T Taylor; Ellen A Robey
Journal:  Cell Mol Life Sci       Date:  2014-03-30       Impact factor: 9.261

Review 6.  The potential and promise of IL-15 in immuno-oncogenic therapies.

Authors:  Tanya O Robinson; Kimberly S Schluns
Journal:  Immunol Lett       Date:  2017-08-16       Impact factor: 3.685

7.  Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice.

Authors:  Qingfeng Chen; Maroun Khoury; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Safety and immunologic effects of IL-15 administration in nonhuman primates.

Authors:  Carolina Berger; Michael Berger; Robert C Hackman; Michael Gough; Carole Elliott; Michael C Jensen; Stanley R Riddell
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

9.  Treadmill exercise promotes interleukin 15 expression in skeletal muscle and interleukin 15 receptor alpha expression in adipose tissue of high-fat diet rats.

Authors:  Hongtao Yang; Jinrui Chang; Wenjia Chen; Lei Zhao; Bo Qu; Chaoshu Tang; Yongfen Qi; Jing Zhang
Journal:  Endocrine       Date:  2012-10-18       Impact factor: 3.633

10.  Novel human interleukin-15 agonists.

Authors:  Xiaoyun Zhu; Warren D Marcus; Wenxin Xu; Hyung-il Lee; Kaiping Han; Jack O Egan; Jason L Yovandich; Peter R Rhode; Hing C Wong
Journal:  J Immunol       Date:  2009-08-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.